» Articles » PMID: 22679504

A Population-based Cohort Study of Mycobacterium Tuberculosis Beijing Strains: an Emerging Public Health Threat in an Immigrant-receiving Country?

Overview
Journal PLoS One
Date 2012 Jun 9
PMID 22679504
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Mycobacterium tuberculosis Beijing strains are frequently associated with tuberculosis outbreaks and drug resistance. However, contradictory evidence and limited study generalizability make it difficult to foresee if the emergence of Beijing strains in high-income immigrant-receiving countries poses an increased public health threat. The purpose of this study was to determine if Beijing strains are associated with high risk disease presentations relative to other strains within Canada.

Methods: This was a retrospective population-based study of culture-confirmed active TB cases in a major immigrant-receiving province of Canada in 1991 through 2007. Of 1,852 eligible cases, 1,826 (99%) were successfully genotyped. Demographic, clinical, and mycobacteriologic surveillance data were combined with molecular diagnostic data. The main outcome measures were site of disease, lung cavitation, sputum smear positivity, bacillary load, and first-line antituberculosis drug resistance.

Results: A total of 350 (19%) patients had Beijing strains; 298 (85%) of these were born in the Western Pacific. Compared to non-Beijing strains, Beijing strains were significantly more likely to be associated with polyresistance (aOR 1.8; 95% CI 1.0-3.3; p = 0.046) and multidrug-resistance (aOR 3.4; 1.0-11.3; p = 0.049). Conversely, Beijing strains were no more likely than non-Beijing strains to be associated with respiratory disease (aOR 1.3; 1.0-1.8; p = 0.053), high bacillary load (aOR 1.2; 0.6-2.7), lung cavitation (aOR 1.0; 0.7-1.5), immediately life-threatening forms of tuberculosis (aOR 0.8; 0.5-1.6), and monoresistance (aOR 0.9; 0.6-1.3). In subgroup analyses, Beijing strains only had a significant association with multidrug-resistant tuberculosis (aOR 6.1; 1.2-30.4), and an association of borderline significance with polyresistant tuberculosis (aOR 1.8; 1.0-3.5; p = 0.062), among individuals born in the Western Pacific.

Conclusion: Other than an increased risk of polyresistant or multidrug-resistant tuberculosis, Beijing strains appear to pose no more of a public health threat than non-Beijing strains within a high-income immigrant-receiving country.

Citing Articles

Dimensions of poverty as risk factors for antimicrobial resistant organisms in Canada: a structured narrative review.

King T, Schindler R, Chavda S, Conly J Antimicrob Resist Infect Control. 2022; 11(1):18.

PMID: 35074013 PMC: 8785485. DOI: 10.1186/s13756-022-01059-1.


Low-Level Rifampin Resistance and Mutations in Mycobacterium tuberculosis: an Analysis of Whole-Genome Sequencing and Drug Susceptibility Test Data in New York.

Shea J, Halse T, Kohlerschmidt D, Lapierre P, Modestil H, Kearns C J Clin Microbiol. 2020; 59(4).

PMID: 32999007 PMC: 8579749. DOI: 10.1128/JCM.01885-20.


Temporal dynamics of Mycobacterium tuberculosis genotypes in New South Wales, Australia.

Gurjav U, Jelfs P, McCallum N, Marais B, Sintchenko V BMC Infect Dis. 2014; 14:455.

PMID: 25149181 PMC: 4262242. DOI: 10.1186/1471-2334-14-455.


A 10-year population based study of 'opt-out' HIV testing of tuberculosis patients in Alberta, Canada: national implications.

Long R, Niruban S, Heffernan C, Cooper R, Fisher D, Ahmed R PLoS One. 2014; 9(6):e98993.

PMID: 24911262 PMC: 4049754. DOI: 10.1371/journal.pone.0098993.


Transmission of Mycobacterium tuberculosis Beijing Strains, Alberta, Canada, 1991-2007.

Langlois-Klassen D, Senthilselvan A, Chui L, Kunimoto D, Saunders L, Menzies D Emerg Infect Dis. 2013; 19(5):701-11.

PMID: 23648234 PMC: 3649004. DOI: 10.3201/eid1905.121578.


References
1.
Kong Y, Cave M, Zhang L, Foxman B, Marrs C, Bates J . Association between Mycobacterium tuberculosis Beijing/W lineage strain infection and extrathoracic tuberculosis: Insights from epidemiologic and clinical characterization of the three principal genetic groups of M. tuberculosis clinical isolates. J Clin Microbiol. 2006; 45(2):409-14. PMC: 1829078. DOI: 10.1128/JCM.01459-06. View

2.
Lan N, Lien H, Tung L, Borgdorff M, Kremer K, van Soolingen D . Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. Emerg Infect Dis. 2004; 9(12):1633-5. PMC: 3034339. DOI: 10.3201/eid0912.030169. View

3.
Sun Y, Lee A, Wong S, Paton N . Association of Mycobacterium tuberculosis Beijing genotype with tuberculosis relapse in Singapore. Epidemiol Infect. 2005; 134(2):329-32. PMC: 2870406. DOI: 10.1017/S095026880500525X. View

4.
Iwamoto T, Yoshida S, Suzuki K, Wada T . Population structure analysis of the Mycobacterium tuberculosis Beijing family indicates an association between certain sublineages and multidrug resistance. Antimicrob Agents Chemother. 2008; 52(10):3805-9. PMC: 2565899. DOI: 10.1128/AAC.00579-08. View

5.
Flores L, Van T, Narayanan S, DeRiemer K, Kato-Maeda M, Gagneux S . Large sequence polymorphisms classify Mycobacterium tuberculosis strains with ancestral spoligotyping patterns. J Clin Microbiol. 2007; 45(10):3393-5. PMC: 2045339. DOI: 10.1128/JCM.00828-07. View